skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: BNN said today the stock which is yielding more than 7.5% at $26 may drop to $13. Barron's is forecasting a price of $20.
What is your opinion going forward? Is it a sell or hold at about $26?
Is the dividend safe?
Thanks
Read Answer Asked by Terry on November 03, 2015
Q: i am sitting on some usa cash as i don't think as a bad thing, but seeing some recommendations coming out on halliberton, and actually got stopped out of kroerger foods, maybe getting back some(canadian) tourmaline, your thoughts or recommendations would be appreciated, or is just having the cash a good thing now
Read Answer Asked by eddie on November 03, 2015
Q: Visa bought Visa Europe but market does not seem to like it!! Can you explain? And what do you think of this stock for a 5 year hold? Plus how do you think the competition is for paying by phone? Thanks.
Read Answer Asked by Dr Lorraine on November 02, 2015
Q: Can you please comment on the acquisition of Visa Europe and whether this is a good entry point? Thx
Read Answer Asked by Patrick on November 02, 2015
Q: It has been a year since you last commented on Syntel. What is your view of the company at this time?
Read Answer Asked by Lloyd on November 02, 2015
Q: Bought Teva in a dip a few years ago and have done pretty well with it. Know they face competition as patents for their MS drug roll off, which I believe represents 50% of their current profits, but never seems to be a bad as analysts predict. See the stock has dipped a bit as they've announced a couple of large acquisitions which look to me to be accretive. Any thoughts on the stock, thinking I might add some more here.
Read Answer Asked by John on November 02, 2015
Q: Hershey had a bad third quarter results. Headline, Hershey cuts forecast on weak demand (slower growth)and higher marketing costs. Hershey's executives are saying. There is a growing gap between low-income and high-income buying patterns. Sanford Bernstein analyst says, there are health and wellness concerns and the premiumization of the chocolate category. Thus, what are your opinions--sell or buy and etc.? Is it a permanent or temporary shift?
Read Answer Asked by Herbert on November 02, 2015
Q: Hello Team,
Could you give me your opinion on this company and how would you rate it compared to csh.
Thank You,
Barry
Read Answer Asked by Barry on November 02, 2015
Q: Hi Peter and gang.
Nice seeing you all at the Money show. I'm looking to get exposure to the US market and I've yet to dip my toe into the ETF field. However the CLU seems to consistently be reported in Money saver in the top ten. Would you recommend this as a way to get diversification in the US and which of the three do you think would be most appropriate. All of my money is invested in Canadian stocks at this time.
GUY
Read Answer Asked by Guy R. on November 02, 2015
Q: NXPI is taking a big beating today. Is it global slow down? Apple had good numbers. Should these stocks be held still or should they be sold. Thank you.
Read Answer Asked by Francis on October 30, 2015
Q: NXP took it on the chin today. Down near 20%. What do you think of NXP's prospects going forward?

TIA
Read Answer Asked by Gerald on October 30, 2015
Q: Peter and team,
I like to add a defence stock to my portfolio. What is your prosq and cons on GD.? Do you have one that you prefer? Or can you provide an ETF or two as well? Thanks for your input. Rossana.
Read Answer Asked by Rossana on October 29, 2015
Q: Hello 5i, Can I please get your views on this shipping company. I came across this company when researching oil shipping companies and then noticed Zaks research had a few upgrades, then the ceo was on BNN today. Their fleet of ships is increasing, their eps seems to be growing as is their dividend. I cannot decipher their book value or their debt levels. thanks
Read Answer Asked by pietro on October 29, 2015
Q: Hi team, I recently sold MCD (in an RRSP) after the run up, and am looking to redeploy cash into a blue chip healthcare or pharma stock in the US. I'm looking for reliable dividends with capital appreciation, and planning to hold for three plus years. MRK and PFE are looking like good candidates, do you have any favourite blue chip healthcare stocks that you think would be a better fit?
Thanks, Alex
Read Answer Asked by Alexander on October 29, 2015
Q: I have $1,000,000 I want to invest in VFV & VCE and I am wondering what time frame is best to make the investments. Should it be over a 1 month or several months, tax loss selling etc. Would you have any recommendation? Thanks for your great service. Bill
Read Answer Asked by William J on October 28, 2015
Q: This is a utility and I've heard from some notable investors that this company's management is good at capital allocation. Looking at the past 4 years they are aggressively bought back shares and refinanced their debt. However, at some point earlier this year this company's stock took a nosedive. Can you share with us your opinion on this stock and if this is a good buy?
Read Answer Asked by Eugene on October 28, 2015
Q: Hi 5i Research team,
Walgreen’s announced a 100% cash take-over Rite Aid at 9$. The competition Bureau will review the transaction (I am relatively optimistic based on the recent Staples/Office Depot merger; the larger size of CVS; and competition from everywhere else in the US market). The closing is forecasted in the second half of 2016. I am wondering what to do (hold / sell on strength? / sell on strength in 2016).
This investment is outside my RRSP/TFSA: meaning large taxable gain (with only a small capital loss earlier this year to net against). The Federal Liberal may change taxation on capital gains before the closing of the transaction. I am using margin in this account: I pay about 2.75% of interest on the full amount backing RAD shares. RAD.US is currently trading around 8$ early Wednesday morning: therefore there is still about 11% of return to be made by waiting. There is an “opportunity cost” to wait, that could also be an “opportunity profit” of not reinvesting before the Fed make its first interest hike and shake the financial markets. The exchange rate could/will change (difficult to forecast, but my anticipations are: US appreciate versus CAD following a US rate hike in early 2016 => so no hurry here). US funds from this transaction will be immediately converted into CAD cash in my account.
Two US lawyers firm lunched a recourse against the board for accepting an offer that is too low, therefore not in the best interest of the shareholders (is there potential upside here?). Is it possible that Walgreen’s rise its offer without a competing bid? Can you reasonably expect a competing bid? If yes, could you named some potential alternative buyers (Walgreen’s has long been the main potential suspect). And finally, there is always the risk of the transaction not closing.
Am I forgetting something? Based on this picture, what do you recommend? Thank you for your advice, Eric
Read Answer Asked by Eric on October 28, 2015
Q: Hi Peter et al.,
I have an overweighting in CDN stocks in my RSP/RIF accounts. Where could I find info on CDN companies who derive their sales/profits mostly in the US? Is there an ETF with such a configuration?
Thanks
Derek
Read Answer Asked by Derek on October 28, 2015
Q: Is this a reasonable partial entry point for a 2-3 year hold ?

Thanks

Read Answer Asked by Dr. Donald on October 28, 2015
Q: I have been watching the following three L-Brands, Ross Stores, Nike for about a year now,and I can not decide which one to invest in. Therefore, I would like any help you can give me to decide which is the one going forward.
Read Answer Asked by Herbert on October 28, 2015